Title |
AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents
|
---|---|
Published in |
PLOS ONE, November 2011
|
DOI | 10.1371/journal.pone.0027270 |
Pubmed ID | |
Authors |
Daniel C.-H. Lin, Jane Zhang, Run Zhuang, Frank Li, Kathy Nguyen, Michael Chen, Thanhvien Tran, Edwin Lopez, Jenny Ying Lin Lu, Xiaoyan Nina Li, Liang Tang, George R. Tonn, Gayathri Swaminath, Jeff D. Reagan, Jin-Long Chen, Hui Tian, Yi-Jyun Lin, Jonathan B. Houze, Jian Luo |
Abstract |
Agonists of GPR40 (FFA1) have been proposed as a means to treat type 2 diabetes. Through lead optimization of a high throughput screening hit, we have identified a novel GPR40 agonist called AMG 837. The objective of these studies was to understand the preclinical pharmacological properties of AMG 837. The activity of AMG 837 on GPR40 was characterized through GTPγS binding, inositol phosphate accumulation and Ca(2+) flux assays. Activity of AMG 837 on insulin release was assessed on isolated primary mouse islets. To determine the anti-diabetic activity of AMG 837 in vivo, we tested AMG 837 using a glucose tolerance test in normal Sprague-Dawley rats and obese Zucker fatty rats. AMG 837 was a potent partial agonist in the calcium flux assay on the GPR40 receptor and potentiated glucose stimulated insulin secretion in vitro and in vivo. Acute administration of AMG 837 lowered glucose excursions and increased glucose stimulated insulin secretion during glucose tolerance tests in both normal and Zucker fatty rats. The improvement in glucose excursions persisted following daily dosing of AMG 837 for 21-days in Zucker fatty rats. Preclinical studies demonstrated that AMG 837 was a potent GPR40 partial agonist which lowered post-prandial glucose levels. These studies support the potential utility of AMG 837 for the treatment of type 2 diabetes. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 4% |
India | 1 | 2% |
Germany | 1 | 2% |
Japan | 1 | 2% |
United States | 1 | 2% |
Unknown | 51 | 89% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 13 | 23% |
Student > Master | 8 | 14% |
Student > Ph. D. Student | 7 | 12% |
Student > Postgraduate | 6 | 11% |
Other | 5 | 9% |
Other | 11 | 19% |
Unknown | 7 | 12% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 14 | 25% |
Biochemistry, Genetics and Molecular Biology | 9 | 16% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 12% |
Medicine and Dentistry | 7 | 12% |
Chemistry | 6 | 11% |
Other | 6 | 11% |
Unknown | 8 | 14% |